DrugPatentWatch Database Preview
Details for Patent: RE41911
» See Plans and Pricing
Which drugs does patent RE41911 protect, and when does it expire?
Patent RE41911 protects IXEMPRA KIT and is included in one NDA.
Protection for IXEMPRA KIT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-eight patent family members in thirty-seven countries.
Summary for Patent: RE41911
Title: | Epothilone derivatives |
Abstract: | The present invention relates to epothilone derivatives, having the following formula ##STR00001## in which the variables G, W, Q, X, Y, B.sub.1, B.sub.2, Z.sub.1, Z.sub.2, and R.sub.1-R.sub.7 are as defined herein, methods for the preparation of the derivatives and intermediates thereof. |
Inventor(s): | Vite; Gregory D. (Titusville, NJ), Kim; Soong-Hoon (Lawrenceville, NJ), Borzilleri; Robert M. (Lawrenceville, NJ) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 12/539,492 |
Patent Claim Types: see list of patent claims | Compound; Use; Composition; |
Drugs Protected by US Patent RE41911
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE41911
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 013358 | Start Trial | |||
Austria | 309236 | Start Trial | |||
Austria | 426598 | Start Trial | |||
Australia | 731497 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |